Status:

COMPLETED

Prevention of Postoperative Delirium With Donepezil

Lead Sponsor:

Technical University of Munich

Collaborating Sponsors:

Eisai Deutschland

Conditions:

Cognitively Normal Elderly Individuals

Eligibility:

All Genders

70+ years

Phase:

PHASE4

Brief Summary

Patients undergoing hip or knee joint replacement at the age of 70 years or above who are cognitively unimpaired will receive donepezil or matching placebo before (over 5-7 days), during and after (ov...

Eligibility Criteria

Inclusion

  • Cognitively healthy, elective hip or knee replacement

Exclusion

  • Ongoing cholinergic treatment, dementia, delirium, acute physical illness

Key Trial Info

Start Date :

January 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 1 2009

Estimated Enrollment :

37 Patients enrolled

Trial Details

Trial ID

NCT00220896

Start Date

January 1 2006

End Date

March 1 2009

Last Update

September 14 2011

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Deps. of Psychiatry and Anaesthesiology, Tech. Universitaet Munich

Munich, Germany, D-81675

Prevention of Postoperative Delirium With Donepezil | DecenTrialz